These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 31843450)

  • 21. Hemophilia in a Changing Treatment Landscape.
    Pelland-Marcotte MC; Carcao MD
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and challenges for hemophilia gene therapy.
    Batty P; Lillicrap D
    Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemophilia gene therapy: ushering in a new treatment paradigm?
    George LA
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):226-233. PubMed ID: 34889378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for hemophilia: Current status and laboratory consequences.
    Batty P; Lillicrap D
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():117-123. PubMed ID: 34288447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gene therapy journey for hemophilia: are we there yet?
    High KA
    Blood; 2012 Nov; 120(23):4482-7. PubMed ID: 22829631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy in an era of emerging treatment options for hemophilia B.
    Monahan PE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S151-60. PubMed ID: 26149016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and improved AAVenues: current status of hemophilia B gene therapy.
    Brimble MA; Reiss UM; Nathwani AC; Davidoff AM
    Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Gene Therapy for Hemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EGD
    Hum Gene Ther; 2017 Nov; 28(11):1004-1012. PubMed ID: 28835123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for hemophilia.
    Nathwani AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):569-578. PubMed ID: 36485127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What´s new in Gene Therapy of Hemophilia.
    Rodriguez-Merchan EC
    Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolic Risks of Non-Factor Replacement Therapies in Hemophilia.
    Tiede A
    Hamostaseologie; 2017; 37(4):307-310. PubMed ID: 29582931
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current developments in hemostatic treatment for patients with hemophilia].
    Nogami K
    Rinsho Ketsueki; 2021; 62(8):1213-1221. PubMed ID: 34497209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.
    Samelson-Jones BJ; Arruda VR
    Front Immunol; 2020; 11():618. PubMed ID: 32425925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of gene therapy for hemophilia: current states and future perspectives].
    Ohmori T
    Rinsho Ketsueki; 2018; 59(10):2238-2246. PubMed ID: 30305531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gene therapy journey for hemophilia: are we there yet?
    High KA
    Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of congenital and acquired hemophilia].
    Higasa S
    Rinsho Ketsueki; 2017; 58(7):857-865. PubMed ID: 28781285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia. After a setback, gene therapy progresses...gingerly.
    Gura T
    Science; 2001 Mar; 291(5509):1692-7. PubMed ID: 11253191
    [No Abstract]   [Full Text] [Related]  

  • 40. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
    Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
    Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.